Trial intelligence / Profile preview

Dose-finding study of SPM 962 in advanced Parkinson's disease with adjunct L-dopa

jRCT2080220282Phase 2

Sponsor
Otsuka Pharmaceutical Co., Ltd.
Start
Jul 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of rotigotine in Parkinson's disease (PD), sponsored by Otsuka Pharmaceutical Co., Ltd.

02

Drugs

rotigotine
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on jRCT2080220282.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080220282.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call